Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-13
1994-08-16
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514299, 514303, 514333, 514381, 514386, 514400, 544244, 544284, 544287, 546 22, 546 23, 546112, 546118, 546276, 546278, 548252, 548253, 548254, 5483007, 5483114, 5483121, 5483151, 5483345, A61K 31435, C07D47104
Patent
active
053387406
ABSTRACT:
The present invention relates to novel heterocyclic derivatives of the formula
REFERENCES:
Buhlmayer, Peter, "Angiotensin-II Antagonists: Patent Activity Since the Discovery of DuP-753," Cardiovasculars, pp. 1693-1718 (1992).
Carpino Philip C.
Da Silva Jardine Paul A.
Wester Ronald T.
Dentz Bernard
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Strassburger Philip C.
LandOfFree
Angiotensin II receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-952011